Keywords
Last Name
Institution

Thomas A. Ullman

TitleASSOCIATE PROFESSOR
InstitutionMount Sinai
DepartmentGastroenterology
Address5 East 98th Street, Dept Of Medicine 11th Floor
New York NY 10029
Phone212-241-4299
Fax212-426-5099

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Maser EA, Sachar DB, Kruse D, Harpaz N, Ullman T, Bauer JJ. High rates of metachronous colon cancer or dysplasia after segmental resection or subtotal colectomy in Crohn's colitis. Inflamm Bowel Dis. 2013 Aug; 19(9):1827-32.
      View in: PubMed
    2. Bernheim O, Colombel JF, Ullman TA, Laharie D, Beaugerie L, Itzkowitz SH. The management of immunosuppression in patients with inflammatory bowel disease and cancer. Gut. 2013 Nov; 62(11):1523-8.
      View in: PubMed
    3. Velayos FS, Ullman TA. Looking forward to understanding and reducing colorectal cancer risk in inflammatory bowel disease. Gastroenterology. 2013 Jul; 145(1):47-9.
      View in: PubMed
    4. Tinsley A, Naymagon S, Enomoto LM, Hollenbeak CS, Sands BE, Ullman TA. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: Results from a tertiary care center. J Crohns Colitis. 2013 Dec 15; 7(12):e635-40.
      View in: PubMed
    5. Leung JM, Davenport M, Wolff MJ, Wiens KE, Abidi WM, Poles MA, Cho I, Ullman T, Mayer L, Loke P. IL-22-producing CD4+ cells are depleted in actively inflamed colitis tissue. Mucosal Immunol. 2014 Jan; 7(1):124-33.
      View in: PubMed
    6. Melmed GY, Siegel CA, Spiegel BM, Allen JI, Cima R, Colombel JF, Dassopoulos T, Denson LA, Dudley-Brown S, Garb A, Hanauer SB, Kappelman MD, Lewis JD, Lynch I, Moynihan A, Rubin DT, Sartor RB, Schwartz RM, Wolf DC, Ullman TA. Quality indicators for inflammatory bowel disease: development of process and outcome measures. Inflamm Bowel Dis. 2013 Mar; 19(3):662-8.
      View in: PubMed
    7. Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, Cohen BL, Pineton de Chambrun G, Asciutti S, Odin JA, Sachar DB, Gaskins HR, Setchell K, Colombel JF, Itzkowitz SH. Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia. Inflamm Bowel Dis. 2013 Feb; 19(2):275-82.
      View in: PubMed
    8. Tinsley A, Naymagon S, Trindade AJ, Sachar DB, Sands BE, Ullman TA. A survey of current practice of venous thromboembolism prophylaxis in hospitalized inflammatory bowel disease patients in the United States. J Clin Gastroenterol. 2013 Jan; 47(1):e1-6.
      View in: PubMed
    9. Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT. Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Mar; 11(3):286-92; quiz e24.
      View in: PubMed
    10. Lazarev M, Present DH, Lichtiger S, Kornbluth A, Marion J, Chapman M, Ullman TA. The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis. J Clin Gastroenterol. 2012 Oct; 46(9):764-7.
      View in: PubMed
    11. Trindade AJ, Tinsley A, Kornbluth A, Ullman TA. The MMAS-8, a screening tool for determining nonadherent behavior, should not be dismissed in IBD. Am J Gastroenterol. 2012 Jun; 107(6):951-2; author reply 952.
      View in: PubMed
    12. Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT, Atzmon G, Barzilai N, Brant SR, Bressman S, Burns ER, Chowers Y, Clark LN, Darvasi A, Doheny D, Duerr RH, Eliakim R, Giladi N, Gregersen PK, Hakonarson H, Jones MR, Marder K, McGovern DP, Mulle J, Orr-Urtreger A, Proctor DD, Pulver A, Rotter JI, Silverberg MS, Ullman T, Warren ST, Waterman M, Zhang W, Bergman A, Mayer L, Katz S, Desnick RJ, Cho JH, Peter I. A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci. PLoS Genet. 2012; 8(3):e1002559.
      View in: PubMed
    13. Ha C, Ullman TA, Siegel CA, Kornbluth A. Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population. Clin Gastroenterol Hepatol. 2012 Sep; 10(9):1002-7; quiz e78.
      View in: PubMed
    14. Trindade AJ, Morisky DE, Ehrlich AC, Tinsley A, Ullman TA. Current practice and perception of screening for medication adherence in inflammatory bowel disease. J Clin Gastroenterol. 2011 Nov-Dec; 45(10):878-82.
      View in: PubMed
    15. Goldstone R, Itzkowitz S, Harpaz N, Ullman T. Progression of low-grade dysplasia in ulcerative colitis: effect of colonic location. Gastrointest Endosc. 2011 Nov; 74(5):1087-93.
      View in: PubMed
    16. Goldstone R, Itzkowitz S, Harpaz N, Ullman T. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance. Inflamm Bowel Dis. 2012 May; 18(5):832-7.
      View in: PubMed
    17. Peter I, Mitchell AA, Ozelius L, Erazo M, Hu J, Doheny D, Abreu MT, Present DH, Ullman T, Benkov K, Korelitz BI, Mayer L, Desnick RJ. Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study. BMC Med Genet. 2011; 12:63.
      View in: PubMed
    18. Ullman TA, Itzkowitz SH. Intestinal inflammation and cancer. Gastroenterology. 2011 May; 140(6):1807-16.
      View in: PubMed
    19. Talley NJ, Abreu MT, Achkar JP, Bernstein CN, Dubinsky MC, Hanauer SB, Kane SV, Sandborn WJ, Ullman TA, Moayyedi P. An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol. 2011 Apr; 106 Suppl 1:S2-25; quiz S26.
      View in: PubMed
    20. Dotan I, Werner L, Vigodman S, Agarwal S, Pfeffer J, Horowitz N, Malter L, Abreu M, Ullman T, Guzner-Gur H, Halpern Z, Mayer L. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines. Inflamm Bowel Dis. 2012 Feb; 18(2):261-8.
      View in: PubMed
    21. Khan KJ, Ullman TA, Ford AC, Abreu MT, Abadir A, Abadir A, Marshall JK, Talley NJ, Moayyedi P. Antibiotic therapy in inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):661-73.
      View in: PubMed
    22. Khan KJ, Dubinsky MC, Ford AC, Ullman TA, Talley NJ, Moayyedi P. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis. Am J Gastroenterol. 2011 Apr; 106(4):630-42.
      View in: PubMed
    23. Kappelman MD, Horvath-Puho E, Sandler RS, Rubin DT, Ullman TA, Pedersen L, Baron JA, Sørensen HT. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011 Jul; 60(7):937-43.
      View in: PubMed
    24. Shah B, Tinsley A, Ullman T. Quality of care in inflammatory bowel disease. Curr Gastroenterol Rep. 2011 Feb; 13(1):87-94.
      View in: PubMed
    25. Trindade AJ, Ehrlich A, Kornbluth A, Ullman TA. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis. 2011 Feb; 17(2):599-604.
      View in: PubMed
    26. Ullman TA. Should chromoendoscopy be the standard of care in ulcerative colitis dysplasia surveillance? Gastroenterol Hepatol (N Y). 2010 Oct; 6(10):616-20.
      View in: PubMed
    27. Park SY, Yoon SJ, Hakomori SI, Kim JM, Kim JY, Bernert B, Ullman T, Itzkowitz SH, Kim JH. Dimeric Le(a) (Le(a)-on-Le(a)) status of beta-haptoglobin in sera of colon cancer, chronic inflammatory disease and normal subjects. Int J Oncol. 2010 May; 36(5):1291-7.
      View in: PubMed
    28. Lazarev M, Ullman T, Schraut WH, Kip KE, Saul M, Regueiro M. Small bowel resection rates in Crohn's disease and the indication for surgery over time: experience from a large tertiary care center. Inflamm Bowel Dis. 2010 May; 16(5):830-5.
      View in: PubMed
    29. Ullman TA. Inflammatory bowel disease-associated cancers: does gender change incidence? Gastroenterology. 2010 May; 138(5):1658-60.
      View in: PubMed
    30. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, Lewis JD, Ullman TA, James T, McLeod R, Burgart LJ, Allen J, Brill JV. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010 Feb; 138(2):738-45.
      View in: PubMed
    31. Park SY, Yoon SJ, Jeong YT, Kim JM, Kim JY, Bernert B, Ullman T, Itzkowitz SH, Kim JH, Hakomori SI. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer. 2010 Jan 1; 126(1):142-55.
      View in: PubMed
    32. Siegel CA, Melmed GY, Ullman TA. Improving quality of care in IBD: a STEEEP challenge. Inflamm Bowel Dis. 2010 Jan; 16(1):134-6.
      View in: PubMed
    33. Sachar DB, Lemmer E, Ibrahim C, Edden Y, Ullman T, Ciardulo J, Roth E, Greenstein AJ, Bauer JJ. Recurrence patterns after first resection for stricturing or penetrating Crohn's disease. Inflamm Bowel Dis. 2009 Jul; 15(7):1071-5.
      View in: PubMed
    34. Ullman T, Odze R, Farraye FA. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon. Inflamm Bowel Dis. 2009 Apr; 15(4):630-8.
      View in: PubMed
    35. Akhtar RY, Lewis BS, Ullman T. Mucosal healing of Crohn's disease demonstrated by capsule endoscopy in a woman with obscure gastrointestinal bleeding. Am J Gastroenterol. 2009 Apr; 104(4):1065-6.
      View in: PubMed
    36. Hefti MM, Chessin DB, Harpaz NH, Steinhagen RM, Ullman TA. Severity of inflammation as a predictor of colectomy in patients with chronic ulcerative colitis. Dis Colon Rectum. 2009 Feb; 52(2):193-7.
      View in: PubMed
    37. Ullman T, Lazarev M. Scope early and often in ulcerative colitis and Crohn's colitis? Gastroenterology. 2009 Feb; 136(2):718-9; discussion 719-20.
      View in: PubMed
    38. Swaminath A, Ullman T, Rosen M, Mayer L, Lichtiger S, Abreu MT. Early clinical experience with adalimumab in treatment of inflammatory bowel disease with infliximab-treated and naïve patients. Aliment Pharmacol Ther. 2009 Feb 1; 29(3):273-8.
      View in: PubMed
    39. Ullman T, Croog V, Harpaz N, Hossain S, Kornbluth A, Bodian C, Itzkowitz S. Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol. 2008 Nov; 6(11):1225-30; quiz 1177.
      View in: PubMed
    40. Maser EA, Deconda D, Lichtiger S, Ullman T, Present DH, Kornbluth A. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Clin Gastroenterol Hepatol. 2008 Oct; 6(10):1112-6.
      View in: PubMed
    41. Marion JF, Waye JD, Present DH, Israel Y, Bodian C, Harpaz N, Chapman M, Itzkowitz S, Steinlauf AF, Abreu MT, Ullman TA, Aisenberg J, Mayer L. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am J Gastroenterol. 2008 Sep; 103(9):2342-9.
      View in: PubMed
    42. Ullman T. Disparities in inflammatory bowel disease care: time to correct a problem. Gastroenterology. 2008 May; 134(5):1617-8; discussion 1618-9.
      View in: PubMed
    43. Rubin DT, Cruz-Correa MR, Gasche C, Jass JR, Lichtenstein GR, Montgomery EA, Riddell RH, Rutter MD, Ullman TA, Velayos FS, Itzkowitz S. Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update. Inflamm Bowel Dis. 2008 Feb; 14(2):265-74.
      View in: PubMed
    44. Murphy SJ, Ullman TA, Abreu MT. Gut microbes in Crohn's disease: getting to know you better? Am J Gastroenterol. 2008 Feb; 103(2):397-8.
      View in: PubMed
    45. Ullman TA. Chromoendoscopy should be the standard method and more widely used for cancer surveillance colonoscopy in ulcerative colitis--con. Inflamm Bowel Dis. 2007 Oct; 13(10):1273-4; discussion 1275-6.
      View in: PubMed
    46. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology. 2007 Oct; 133(4):1099-105; quiz 1340-1.
      View in: PubMed
    47. Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2007 Apr; 13(4):367-71.
      View in: PubMed
    48. Ullman TA. Tacrolimus for active ulcerative colitis? Yes! (Even though Cochrane says "no"). Gastroenterology. 2007 Mar; 132(3):1192-4; discussin 1194-5.
      View in: PubMed
    49. Ullman TA, Palmon R. The certain uncertainty of measuring disease activity in IBD. J Clin Gastroenterol. 2007 Feb; 41(2):123-5.
      View in: PubMed
    50. Brown SJ, Ullman T, Sachar DB. Filtering out the phagocytes in inflammatory bowel disease. J Clin Gastroenterol. 2005 Nov-Dec; 39(10):845-6.
      View in: PubMed
    51. Matula S, Croog V, Itzkowitz S, Harpaz N, Bodian C, Hossain S, Ullman T. Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine. Clin Gastroenterol Hepatol. 2005 Oct; 3(10):1015-21.
      View in: PubMed
    52. Ullman TA. Colonoscopic surveillance in inflammatory bowel disease. Curr Opin Gastroenterol. 2005 Sep; 21(5):585-8.
      View in: PubMed
    53. Banikazemi M, Ullman T, Desnick RJ. Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy. Mol Genet Metab. 2005 Aug; 85(4):255-9.
      View in: PubMed
    54. Ullman TA. Preventing neoplastic progression in ulcerative colitis. J Clin Gastroenterol. 2005 Apr; 39(4 Suppl 2):S66-9.
      View in: PubMed
    55. Itzkowitz S, Ullman T. The world isn't flat. Gastrointest Endosc. 2004 Sep; 60(3):426-7.
      View in: PubMed
    56. Robert ME, Skacel M, Ullman T, Bernstein CN, Easley K, Goldblum JR. Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases. Am J Clin Pathol. 2004 Jul; 122(1):94-9.
      View in: PubMed
    57. Ullman T, Croog V, Harpaz N, Sachar D, Itzkowitz S. Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology. 2003 Nov; 125(5):1311-9.
      View in: PubMed
    58. Ullman T. Hold the bone: good news for young women with IBD. Inflamm Bowel Dis. 2003 Nov; 9(6):396-7.
      View in: PubMed
    59. Ullman TA. Patients with low-grade dysplasia should be advised to undergo colectomy. Inflamm Bowel Dis. 2003 Jul; 9(4):267-9; discussion 273-5.
      View in: PubMed
    60. Ullman TA. Dysplasia and colorectal cancer in Crohn's disease. J Clin Gastroenterol. 2003 May-Jun; 36(5 Suppl):S75-8; discussion S94-6.
      View in: PubMed
    61. Croog VJ, Ullman TA, Itzkowitz SH. Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis. 2003 Sep; 18(5):392-400.
      View in: PubMed
    62. Ullman TA. Making the grade: should patients with UC and low-grade dysplasia graduate to surgery or be held back? Inflamm Bowel Dis. 2002 Nov; 8(6):430-1.
      View in: PubMed
    63. Ullman TA, Loftus EV, Kakar S, Burgart LJ, Sandborn WJ, Tremaine WJ. The fate of low grade dysplasia in ulcerative colitis. Am J Gastroenterol. 2002 Apr; 97(4):922-7.
      View in: PubMed
    64. Ullman TA. Markov Polo: finding the costs of Crohn's in an Olmstead County pool. Inflamm Bowel Dis. 2000 Feb; 6(1):64-5.
      View in: PubMed
    65. Ullman T, Korzenik JR. Yogurt as oral bacteriotherapy for diarrhea: back to the future? Indian Pediatr. 1998 Jun; 35(6):503-6.
      View in: PubMed
    66. Ullman T, Reding M. Gastrointestinal dysfunction in stroke. Semin Neurol. 1996 Sep; 16(3):269-75.
      View in: PubMed
    67. Muschler GF, Huber B, Ullman T, Barth R, Easley K, Otis JO, Lane JM. Evaluation of bone-grafting materials in a new canine segmental spinal fusion model. J Orthop Res. 1993 Jul; 11(4):514-24.
      View in: PubMed
    Ullman's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067